Full Course: 20 AMA PRA Category 1 Credits™ for CME / CEU / CPD
Short Course: 10 AMA PRA Category 1 Credits™ for CME / CEU / CPD
Course(s) are appropriate for: Emergency Physicians, Pediatricians, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)
Series 17 (DI17) Topics Include: Diabetes Management for Elderly Patients, Overtreatment of Patients with Diabetes, Type 2 Diabetes Vitamin Deficiencies, Relationships Between Diabetes and Heart Failure, and more.
To view topic outline of the full or short course, select the Course Type (Full or Short) below:
Full Course:
DI17
Full Course Price:
$580
Short Course:
DI17A, DI17B
Short Course Price:
$485
Format:
Available in Audio format.
Course Topics
Psychosocial Guidelines and Implementation/Cognitive Decline
Identify patients at risk for psychosocial issues that could interfere with self-management of diabetes; Address psychosocial issues when discussing biologic, behavioral, and quality of life goals for self-management of diabetes; Utilize community resources and alternative modes of health care delivery to improve management of patients with diabetes who have limited access to health care; Recognize early stages of cognitive decline and implement management strategies according to the patient's needs and capabilities.
Diabetes in Long-Term Care Facilities/Pediatric Diabetes/Vitamin Deficiencies, Supplements, and Diabetes
Implement management strategies appropriate for differing types of long-term care facilities and a variety of comorbidities among patients; Establish appropriate treatment goals and monitoring of glycemic control in patients residing in long-term care facilities; Utilize diagnostic testing and family history to identify the type of diabetes present in a pediatric patient; Identify common vitamin deficiencies associated with type 2 diabetes and choose high-quality supplements.
Medical vs Surgical Treatment of Obesity in Diabetes/Diabetes in the Elderly
Compare medical and surgical approaches to the management of obesity and evaluate their outcomes in patients with diabetes; Identify preoperative factors that predict long-term remission of diabetes after bariatric surgery; Adjust goals for glycemic control in elderly patients based on comorbidities, geriatric syndromes, and life expectancy; Customize diabetes management for elderly patients based on their level of independence, degree of frailty, and income.
The Language of Diabites/Metformin, Type 1 Diabetes, and Removal Trial/Metal, Cardiovascular Risk, and Chelation Therapy
Use language that is person-centered, empowering, and strengths-based to discuss diabetes management with patients; Summarize the cardiovascular benefits and possible side effects of metformin for patients with type 1 diabetes; Discuss the cardiovascular effects of chelation therapy for patients with diabetes and history of myocardial infarction; Describe the mechanism through which exposure to metals induces endothelial dysfunction and further increases risk for cardiovascular disease in patients with diabetes.
Diabetes and the Heart: Antithrombotic Therapy/Kidney Disease/Dyslipidemia
Summarize the benefits and risks of dual vs single antiplatelet therapy for primary and secondary prevention of ischemic events; Compare the effects of new-generation adenosine diphosphate receptor agonists on the incidence of ischemic events and major bleeding in patients with diabetes; Explain how the interrelationship between diabetes, heart failure, and kidney disease affects response to treatment for heart failure; Describe the pathophysiology and characteristic lipid profile of diabetic dyslipidemia.
Diabetes and Heart Failure / New Definitions and Approaches to Diabetes
Summarize the relationship between diabetes, heart failure, and risks for mortality; Discuss the structural, metabolic, and autonomic changes that occur with diabetes and heart failure; Identify factors associated with more rapid rate of progression to type 1 and type 2 diabetes; Categorize patients with diabetes based on baseline autoantibody levels, hemoglobin A1c, age, and insulin resistance.
Glucose Control and the Brain/Overtreatment of Type 2 Diabetes
Explain why brain-mediated mechanisms of blood glucose control may be an optimal target for achieving sustained remission of type 2 diabetes; Describe potential mechanisms through which the brain mediates alterations in pancreatic B-cell function in type 2 diabetes; Discuss the risk factors for and consequences of overtreatment in patients with diabetes; Identify patient and physician factors that contribute to overtreatment of patients with diabetes.
Physical Activity and Exercise / Distress and Depression
Summarize the 2016 position statement from the American Diabetes Association about activity and exercise recommendations for patients with all types of diabetes; Explain the role of progressive resistance exercise in management of diabetes, particularly in older adults; Compare and contrast the time course and characteristics of depression in patients with type 2 diabetes relative to depression in the general population; Discuss ways of implementing community-based interventions to treat depression and improve glycemic control in patients with type?2 diabetes.
Cardiac Outcomes with GLP-1 Agonists and DPP-4 Inhibitors/The Gut and Metformin/The Diabetic Diet
Review results and controversies in cardiovascular outcomes trials of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists; Discuss the bioavailability and the metabolic, hormonal, and gastrointestinal effects of metformin; Provide self-management education and nutrition therapy customized to patient preferences, health conditions, and medications; Summarize the benefits and drawbacks of different management strategies for improving glycemic control and weight loss in patients with type 2 diabetes.
Treating Type 1 Diabetes / A New Continuous Glucose Monitor
Summarize reasons for the limited availability of insulin worldwide; Identify factors associated with episodes of severe hypoglycemia in patients with long-standing type 1 diabetes; Discuss new technologic advances that may help improve efficiency of glucose monitoring for patients and their providers; Instruct patients on how to adjust insulin dosing for exercise to prevent hypoglycemia.
Psychosocial Guidelines and Implementation/Cognitive Decline
Identify patients at risk for psychosocial issues that could interfere with self-management of diabetes; Address psychosocial issues when discussing biologic, behavioral, and quality of life goals for self-management of diabetes; Utilize community resources and alternative modes of health care delivery to improve management of patients with diabetes who have limited access to health care; Recognize early stages of cognitive decline and implement management strategies according to the patient's needs and capabilities.
Medical vs Surgical Treatment of Obesity in Diabetes/Diabetes in the Elderly
Compare medical and surgical approaches to the management of obesity and evaluate their outcomes in patients with diabetes; Identify preoperative factors that predict long-term remission of diabetes after bariatric surgery; Adjust goals for glycemic control in elderly patients based on comorbidities, geriatric syndromes, and life expectancy; Customize diabetes management for elderly patients based on their level of independence, degree of frailty, and income.
Diabetes and the Heart: Antithrombotic Therapy/Kidney Disease/Dyslipidemia
Summarize the benefits and risks of dual vs single antiplatelet therapy for primary and secondary prevention of ischemic events; Compare the effects of new-generation adenosine diphosphate receptor agonists on the incidence of ischemic events and major bleeding in patients with diabetes; Explain how the interrelationship between diabetes, heart failure, and kidney disease affects response to treatment for heart failure; Describe the pathophysiology and characteristic lipid profile of diabetic dyslipidemia.
Glucose Control and the Brain/Overtreatment of Type 2 Diabetes
Explain why brain-mediated mechanisms of blood glucose control may be an optimal target for achieving sustained remission of type 2 diabetes; Describe potential mechanisms through which the brain mediates alterations in pancreatic B-cell function in type 2 diabetes; Discuss the risk factors for and consequences of overtreatment in patients with diabetes; Identify patient and physician factors that contribute to overtreatment of patients with diabetes.
Cardiac Outcomes with GLP-1 Agonists and DPP-4 Inhibitors/The Gut and Metformin/The Diabetic Diet
Review results and controversies in cardiovascular outcomes trials of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists; Discuss the bioavailability and the metabolic, hormonal, and gastrointestinal effects of metformin; Provide self-management education and nutrition therapy customized to patient preferences, health conditions, and medications; Summarize the benefits and drawbacks of different management strategies for improving glycemic control and weight loss in patients with type 2 diabetes.
Diabetes in Long-Term Care Facilities/Pediatric Diabetes/Vitamin Deficiencies, Supplements, and Diabetes
Implement management strategies appropriate for differing types of long-term care facilities and a variety of comorbidities among patients; Establish appropriate treatment goals and monitoring of glycemic control in patients residing in long-term care facilities; Utilize diagnostic testing and family history to identify the type of diabetes present in a pediatric patient; Identify common vitamin deficiencies associated with type 2 diabetes and choose high-quality supplements.
The Language of Diabites/Metformin, Type 1 Diabetes, and Removal Trial/Metal, Cardiovascular Risk, and Chelation Therapy
Use language that is person-centered, empowering, and strengths-based to discuss diabetes management with patients; Summarize the cardiovascular benefits and possible side effects of metformin for patients with type 1 diabetes; Discuss the cardiovascular effects of chelation therapy for patients with diabetes and history of myocardial infarction; Describe the mechanism through which exposure to metals induces endothelial dysfunction and further increases risk for cardiovascular disease in patients with diabetes.
Diabetes and Heart Failure / New Definitions and Approaches to Diabetes
Summarize the relationship between diabetes, heart failure, and risks for mortality; Discuss the structural, metabolic, and autonomic changes that occur with diabetes and heart failure; Identify factors associated with more rapid rate of progression to type 1 and type 2 diabetes; Categorize patients with diabetes based on baseline autoantibody levels, hemoglobin A1c, age, and insulin resistance.
Physical Activity and Exercise / Distress and Depression
Summarize the 2016 position statement from the American Diabetes Association about activity and exercise recommendations for patients with all types of diabetes; Explain the role of progressive resistance exercise in management of diabetes, particularly in older adults; Compare and contrast the time course and characteristics of depression in patients with type 2 diabetes relative to depression in the general population; Discuss ways of implementing community-based interventions to treat depression and improve glycemic control in patients with type?2 diabetes.
Treating Type 1 Diabetes / A New Continuous Glucose Monitor
Summarize reasons for the limited availability of insulin worldwide; Identify factors associated with episodes of severe hypoglycemia in patients with long-standing type 1 diabetes; Discuss new technologic advances that may help improve efficiency of glucose monitoring for patients and their providers; Instruct patients on how to adjust insulin dosing for exercise to prevent hypoglycemia.
Additional Information
Additional Continuing Medical Education options available:
If you have taken the current Diabetes CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon. There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.
Diabetes Seminar CME / CPD
Full Course: 20 AMA PRA Category 1 Credits™ for CME / CEU / CPD
Short Course: 10 AMA PRA Category 1 Credits™ for CME / CEU / CPD
Course(s) are appropriate for: Emergency Physicians, Pediatricians, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)
Series 17 (DI17) Topics Include: Diabetes Management for Elderly Patients, Overtreatment of Patients with Diabetes, Type 2 Diabetes Vitamin Deficiencies, Relationships Between Diabetes and Heart Failure, and more.
To view topic outline of the full or short course, select the Course Type (Full or Short) below:
Course Topics
Psychosocial Guidelines and Implementation/Cognitive Decline
Identify patients at risk for psychosocial issues that could interfere with self-management of diabetes; Address psychosocial issues when discussing biologic, behavioral, and quality of life goals for self-management of diabetes; Utilize community resources and alternative modes of health care delivery to improve management of patients with diabetes who have limited access to health care; Recognize early stages of cognitive decline and implement management strategies according to the patient's needs and capabilities.
Diabetes in Long-Term Care Facilities/Pediatric Diabetes/Vitamin Deficiencies, Supplements, and Diabetes
Implement management strategies appropriate for differing types of long-term care facilities and a variety of comorbidities among patients; Establish appropriate treatment goals and monitoring of glycemic control in patients residing in long-term care facilities; Utilize diagnostic testing and family history to identify the type of diabetes present in a pediatric patient; Identify common vitamin deficiencies associated with type 2 diabetes and choose high-quality supplements.
Medical vs Surgical Treatment of Obesity in Diabetes/Diabetes in the Elderly
Compare medical and surgical approaches to the management of obesity and evaluate their outcomes in patients with diabetes; Identify preoperative factors that predict long-term remission of diabetes after bariatric surgery; Adjust goals for glycemic control in elderly patients based on comorbidities, geriatric syndromes, and life expectancy; Customize diabetes management for elderly patients based on their level of independence, degree of frailty, and income.
The Language of Diabites/Metformin, Type 1 Diabetes, and Removal Trial/Metal, Cardiovascular Risk, and Chelation Therapy
Use language that is person-centered, empowering, and strengths-based to discuss diabetes management with patients; Summarize the cardiovascular benefits and possible side effects of metformin for patients with type 1 diabetes; Discuss the cardiovascular effects of chelation therapy for patients with diabetes and history of myocardial infarction; Describe the mechanism through which exposure to metals induces endothelial dysfunction and further increases risk for cardiovascular disease in patients with diabetes.
Diabetes and the Heart: Antithrombotic Therapy/Kidney Disease/Dyslipidemia
Summarize the benefits and risks of dual vs single antiplatelet therapy for primary and secondary prevention of ischemic events; Compare the effects of new-generation adenosine diphosphate receptor agonists on the incidence of ischemic events and major bleeding in patients with diabetes; Explain how the interrelationship between diabetes, heart failure, and kidney disease affects response to treatment for heart failure; Describe the pathophysiology and characteristic lipid profile of diabetic dyslipidemia.
Diabetes and Heart Failure / New Definitions and Approaches to Diabetes
Summarize the relationship between diabetes, heart failure, and risks for mortality; Discuss the structural, metabolic, and autonomic changes that occur with diabetes and heart failure; Identify factors associated with more rapid rate of progression to type 1 and type 2 diabetes; Categorize patients with diabetes based on baseline autoantibody levels, hemoglobin A1c, age, and insulin resistance.
Glucose Control and the Brain/Overtreatment of Type 2 Diabetes
Explain why brain-mediated mechanisms of blood glucose control may be an optimal target for achieving sustained remission of type 2 diabetes; Describe potential mechanisms through which the brain mediates alterations in pancreatic B-cell function in type 2 diabetes; Discuss the risk factors for and consequences of overtreatment in patients with diabetes; Identify patient and physician factors that contribute to overtreatment of patients with diabetes.
Physical Activity and Exercise / Distress and Depression
Summarize the 2016 position statement from the American Diabetes Association about activity and exercise recommendations for patients with all types of diabetes; Explain the role of progressive resistance exercise in management of diabetes, particularly in older adults; Compare and contrast the time course and characteristics of depression in patients with type 2 diabetes relative to depression in the general population; Discuss ways of implementing community-based interventions to treat depression and improve glycemic control in patients with type?2 diabetes.
Cardiac Outcomes with GLP-1 Agonists and DPP-4 Inhibitors/The Gut and Metformin/The Diabetic Diet
Review results and controversies in cardiovascular outcomes trials of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists; Discuss the bioavailability and the metabolic, hormonal, and gastrointestinal effects of metformin; Provide self-management education and nutrition therapy customized to patient preferences, health conditions, and medications; Summarize the benefits and drawbacks of different management strategies for improving glycemic control and weight loss in patients with type 2 diabetes.
Treating Type 1 Diabetes / A New Continuous Glucose Monitor
Summarize reasons for the limited availability of insulin worldwide; Identify factors associated with episodes of severe hypoglycemia in patients with long-standing type 1 diabetes; Discuss new technologic advances that may help improve efficiency of glucose monitoring for patients and their providers; Instruct patients on how to adjust insulin dosing for exercise to prevent hypoglycemia.
Psychosocial Guidelines and Implementation/Cognitive Decline
Identify patients at risk for psychosocial issues that could interfere with self-management of diabetes; Address psychosocial issues when discussing biologic, behavioral, and quality of life goals for self-management of diabetes; Utilize community resources and alternative modes of health care delivery to improve management of patients with diabetes who have limited access to health care; Recognize early stages of cognitive decline and implement management strategies according to the patient's needs and capabilities.
Medical vs Surgical Treatment of Obesity in Diabetes/Diabetes in the Elderly
Compare medical and surgical approaches to the management of obesity and evaluate their outcomes in patients with diabetes; Identify preoperative factors that predict long-term remission of diabetes after bariatric surgery; Adjust goals for glycemic control in elderly patients based on comorbidities, geriatric syndromes, and life expectancy; Customize diabetes management for elderly patients based on their level of independence, degree of frailty, and income.
Diabetes and the Heart: Antithrombotic Therapy/Kidney Disease/Dyslipidemia
Summarize the benefits and risks of dual vs single antiplatelet therapy for primary and secondary prevention of ischemic events; Compare the effects of new-generation adenosine diphosphate receptor agonists on the incidence of ischemic events and major bleeding in patients with diabetes; Explain how the interrelationship between diabetes, heart failure, and kidney disease affects response to treatment for heart failure; Describe the pathophysiology and characteristic lipid profile of diabetic dyslipidemia.
Glucose Control and the Brain/Overtreatment of Type 2 Diabetes
Explain why brain-mediated mechanisms of blood glucose control may be an optimal target for achieving sustained remission of type 2 diabetes; Describe potential mechanisms through which the brain mediates alterations in pancreatic B-cell function in type 2 diabetes; Discuss the risk factors for and consequences of overtreatment in patients with diabetes; Identify patient and physician factors that contribute to overtreatment of patients with diabetes.
Cardiac Outcomes with GLP-1 Agonists and DPP-4 Inhibitors/The Gut and Metformin/The Diabetic Diet
Review results and controversies in cardiovascular outcomes trials of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists; Discuss the bioavailability and the metabolic, hormonal, and gastrointestinal effects of metformin; Provide self-management education and nutrition therapy customized to patient preferences, health conditions, and medications; Summarize the benefits and drawbacks of different management strategies for improving glycemic control and weight loss in patients with type 2 diabetes.
Diabetes in Long-Term Care Facilities/Pediatric Diabetes/Vitamin Deficiencies, Supplements, and Diabetes
Implement management strategies appropriate for differing types of long-term care facilities and a variety of comorbidities among patients; Establish appropriate treatment goals and monitoring of glycemic control in patients residing in long-term care facilities; Utilize diagnostic testing and family history to identify the type of diabetes present in a pediatric patient; Identify common vitamin deficiencies associated with type 2 diabetes and choose high-quality supplements.
The Language of Diabites/Metformin, Type 1 Diabetes, and Removal Trial/Metal, Cardiovascular Risk, and Chelation Therapy
Use language that is person-centered, empowering, and strengths-based to discuss diabetes management with patients; Summarize the cardiovascular benefits and possible side effects of metformin for patients with type 1 diabetes; Discuss the cardiovascular effects of chelation therapy for patients with diabetes and history of myocardial infarction; Describe the mechanism through which exposure to metals induces endothelial dysfunction and further increases risk for cardiovascular disease in patients with diabetes.
Diabetes and Heart Failure / New Definitions and Approaches to Diabetes
Summarize the relationship between diabetes, heart failure, and risks for mortality; Discuss the structural, metabolic, and autonomic changes that occur with diabetes and heart failure; Identify factors associated with more rapid rate of progression to type 1 and type 2 diabetes; Categorize patients with diabetes based on baseline autoantibody levels, hemoglobin A1c, age, and insulin resistance.
Physical Activity and Exercise / Distress and Depression
Summarize the 2016 position statement from the American Diabetes Association about activity and exercise recommendations for patients with all types of diabetes; Explain the role of progressive resistance exercise in management of diabetes, particularly in older adults; Compare and contrast the time course and characteristics of depression in patients with type 2 diabetes relative to depression in the general population; Discuss ways of implementing community-based interventions to treat depression and improve glycemic control in patients with type?2 diabetes.
Treating Type 1 Diabetes / A New Continuous Glucose Monitor
Summarize reasons for the limited availability of insulin worldwide; Identify factors associated with episodes of severe hypoglycemia in patients with long-standing type 1 diabetes; Discuss new technologic advances that may help improve efficiency of glucose monitoring for patients and their providers; Instruct patients on how to adjust insulin dosing for exercise to prevent hypoglycemia.
Additional Information
Additional Continuing Medical Education options available:
Other courses of interest may include: Pediatrics, Family Practice, Internal Medicine, Obesity, and Nutrition
If you have taken the current Diabetes CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon. There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.